[Possibilities and limits of chemotherapy in multi-modality treatment of urinary bladder cancer].
Rüther
U
U
Rassweiler
J
J
Lüthgens
M
M
Bub
P
P
Jipp
P
P
Eisenberger
F
F
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage
D015251:Epirubicin; D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate
Möglichkeiten und Grenzen der Chemotherapie bei der multimodalen Therapie des Harnblasenkarzinoms.